1. Home
  2. Two ‘missing’ MLAs reach Vidhana Soudha ahead of floor test, join Congress camp

Two ‘missing’ MLAs reach Vidhana Soudha ahead of floor test, join Congress camp

News Network
May 19, 2018

Bengaluru, May 19: The floor test in the Karnataka Assembly is scheduled for 4 pm today, as per the Supreme Court order. Senior BJP MLA K.G. Bopaiah, who was appointed as the Pro Tem Speaker by Governor Vajubhai Vala, will oversee the proceedings, which will also be telecast live.

BJP, with 104 seats, is seven short of the required number of 111. The Congress with 78 MLAs, the JD(S) with 36 and three others are also individually not in a position to form the government.

Assembly session began at 11 am on Saturday morning and the newly-elected MLAs took were sworn into the Karnataka Assembly. Chief Minister B.S. Yeddyurappa was sworn in alone on Friday morning by Governor Vajubhai Vala.

Pratapgouda Patil, the Congress MLA from Maski who went missing and was said to have joined the BJP camp, reached Vidhana soudha a few minutes earlier, sources said. He was said to have been holed up in a private hotel in Bengaluru.

Congress leaders issued the party whip to the MLA. BJP MLA S.R. Viswanath was seen trying to take the MLA away, but he refused and joined the Congress camp.

Anand Singh, the missing Congress MLA also reached Vidhana Soudha, along with his wife and son. He was welcomed by D.K. Shivakumar and taken inside.

Massive security arrangements

As per the directions of the apex court, the police have made massive security arrangements in and around the Vidhana Soudha, the seat of state legislature, for the smooth conduct of the floor test, reports news agency.

Public entry to the Vidhana Soudha has been restricted and officials and staff of the Secretariat are being allowed to enter the premises after thorough checks.

120 marshals of legislative assembly and 80 marshals of legislative council have been deployed today.

Comments

Shashi
 - 
Saturday, 19 May 2018

BJP doing strange things. Feku and shah scripting all these dramas

Farooq
 - 
Saturday, 19 May 2018

BJP will sabotage the floor test, no doubt in that

Ravi
 - 
Saturday, 19 May 2018

Nobody can predict BJP dirty tricks

Danish
 - 
Saturday, 19 May 2018

BJP politricks will be a milestone in Karnataka political history

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
July 29,2020

Bengaluru Jul 29: There will be a centralised system in place in Karnataka to classify asymptomatic, symptomatic and mild symptomatic persons and recommend treatment based on the severity of the cases, said Medical Education Minister Dr K Sudhakar on Tuesday here.

"Various existing apps related to COVID-19 will be brought under one platform to get real-time information which will assist in strategising allocation of hospitals/beds to the needy. This will probably remove the delay in bed allocation and treatment which is being faced now. The patients will get all information in one phone call," Dr Sudhakar said.

Sudhakar spoke with a team of experts from the government and Infosys.

Referring to a company by name Step 1, which is providing such services in Delhi and Madhya Pradesh, the Minister said that a similar system will be implemented in the state as well.

"This company is having a team of doctors and nurses which is guiding the people whether they need hospital treatment or home isolation after they are tested positive for COVID-19. More than 70 per cent of the positive cases are being asymptomatic or mildly symptomatic and are advised to go for home isolation," the minister said.

"The load on the hospitals is reduced and severe cases can be administered proper treatment. Infosys co-ordinates with the government to provide technical support for this system," Dr Sudhakar added.

Earlier during the day, the minister held a video conference with the heads of private medical colleges to review COVID preparedness.
The government has already passed guidelines to allocate 50 per cent of hospital beds for COVID patients.

Comments

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 2,2020

Udupi, May 2: All the 18 people who were advised self-quarantine in connection with the Thekkatte petrol bunk incident have been tested negative, however, they were asked to continue the 14-day quarantine, said DHO Sudhirchandra Suda on Saturday.

the petrol bunk at Thekkatte was sealed after a Covid infected person had food and took bath at the petrol bunk, while he was travelling from Mumbai to Mandya.

The employees and the owner of the petrol bunk along with the six employees at Sasthana toll gate were asked to quarantine themselves for 14 days.

Comments

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
coastaldigest.com web desk
July 1,2020

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Comments

Add new comment

About text formats
  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.